NFCR believes that the best path to ending cancer in our lifetime is to invest heavily in high-risk/high-reward research that will yield long-term impacts in patient outcomes. Other organizations have done an outstanding job bringing awareness to the public, now is the time to act and move forward towards a cure! Read Our Financials & 990

Research & Education


$25-$100 – Stains one tissue slide from a tumor biopsy to look for a predictive biomarker of cancer metastasis

$100  –  Performs one biopsy to get tumor tissues from a patient for a variety of pathological tests and biological analyses

$250 – Buys one case of petri dishes for growing cancer cells – an essential first step to identify tumor markers or test treatment effectiveness of new drugs

$500-750 – Buys one antibody test to determine whether tumor cells have a specific marker for drug resistance

$1,000 – Carries out a comprehensive genome-wide analysis on all genes in one tumor sample, for developing targeted and personalized cancer therapies

WiseGivng Donor Handbook
Click to Read

NFCR is proud to be a trusted steward of our supporters’ philanthropic gifts. We are an accredited charity, as reviewed by the Better Business Bureau. Read more in the BBB’s latest WiseGiving Donor Handbook.